News
Zepbound Bests Wegovy for Weight Loss in New Trial
WEDNESDAY, Dec. 4, 2024 -- Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
"Given the increased interest around obesity medications, we conducted...
→
Many Women With Epilepsy Unaware of Seizure Meds' Risks to Pregnancy
FRIDAY, Dec. 6, 2024 -- Many women with epilepsy who are of childbearing age might not realize their anti-seizure drugs can raise the risk of birth defects or dampen the effectiveness of their birth control, a new study warns.
Likewise, some birth...
→
Eating Ultra-processed Foods Could Add Fat to Your Thighs
FRIDAY, Dec. 6, 2024 -- Eating lots of ultra-processed foods appears linked to a buildup of fat in the thighs, which in turn raises a person's odds for arthritis in the knees, new research shows.
“In an adult population at risk for but...
→
03:58
